Skip to content
Screener

HealthEquity HQY Q2 2026 earnings

Reported September 2, 2025 · After market close

Revenue$325.8MBeat by $5.1M
EPS$1.08Beat by $0.17
Revenue estimate$320.7M
EPS estimate$0.91

Next report

Date not yet announced

Financials

Q2 2026

Income statement

See full
Revenue$325.8M+8.6%
Gross profit$232.6M+14.0%
Operating income$89.6M+52.1%
Net income$59.9M+67.1%
EPS (diluted)$0.68+70.0%

Balance sheet

See full
Cash & equivalents$304.5M-6.9%
Total debt$1.1B-8.8%
Total equity$2.1B-0.5%
Total assets$3.4B-2.8%

Cash flow

See full
Operating cash flow$135.9M+25.7%
CapEx$773.0K+4.3%
Free cash flow$135.1M+25.8%

Valuation & ratios

Valuation

as of 07/31/25
See full
Market cap$8.39B+23.6%
Enterprise value$9.14B+20.0%
P/E57.5×-6.7×
P/S6.6×+0.4×

Profitability

See full
Gross margin66.4%+1.5pp
Operating margin18.5%+3.0pp
Net margin11.5%+1.9pp
FCF margin28.8%+1.0pp

Returns & leverage

See full
Return on equity6.8%+1.6pp
Debt / equity0.5×0.0×
Current ratio4.2×+0.1×

Segments

By product

See full
Custodial revenue$159.9M+15.3%
Service revenue$117.9M+1.0%
Interchange revenue$48.1M+8.0%

FAQ

When did HealthEquity report Q2 2026 earnings?
HealthEquity (HQY) reported Q2 2026 earnings on September 2, 2025 after market close.
What were HealthEquity's Q2 2026 revenue and EPS?
HealthEquity reported revenue of $325.8M and eps of $1.08 for Q2 2026.
Did HealthEquity beat estimates in Q2 2026?
Revenue beat the consensus estimate of $320.7M by $5.1M. EPS beat the consensus estimate of $0.91 by $0.17.
How did HealthEquity's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 8.6% from $299.9M a year earlier and eps grew 25.6% from $0.86.
Where can I find HealthEquity's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001428336-25-000028) and the 10-Q periodic report (0001428336-25-000029) directly on SEC EDGAR. The filing index links above go to sec.gov.